Arthur Allen

The FDA's recent decision to withhold approval of a new skin cancer treatment fell like a hammer on doctors who treat melanoma and patients who saw

Questions over trial design and political pressure shadowed the rejection of Replimune’s RP1 treatment.

The FDA's recent decision to withhold approval of a new skin cancer treatment fell like a hammer on doctors who treat melanoma and patients who saw

The FDA's recent decision to withhold approval of a new skin cancer treatment fell like a hammer on doctors who treat melanoma and patients who saw

We appreciate you here at HealthDay. Please sign up for unlimited health news!

In 1996, Guinea-Bissau seemed like an ideal research post for budding pediatrician Lone Graff Stensballe.

'They became more strident in saying that their findings were real,' says one expert

In 1996, Guinea-Bissau seemed like an ideal research post for budding pediatrician Lone Graff Stensballe.

In 1996, Guinea-Bissau seemed like an ideal research post for budding pediatrician Lone Graff Stensballe.

The work of Peter Aaby and Christine Stabell Benn has long been controversial. Until Robert F. Kennedy Jr. became the U.S. health policy chief, most vaccine scientists tended to ignore it. That has changed.